References

Prevalence of industry ties in the US cancer ecosystem: a systematic review and meta-analysis

External reference

Are financial payments from the pharmaceutical industry associated with physician prescribing? a systematic review

10.7326/m20-5665 · 2021 · External reference

Pharmaceutical industry–sponsored meals and physician prescribing patterns for Medicare beneficiaries

10.1001/jamainternmed.2016.2765 · 2016 · External reference

Association of industry payments to physicians with the prescribing of brand-name statins in Massachusetts

10.1001/jamainternmed.2016.1709 · 2016 · External reference

Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort study

10.1136/bmj-2023-075512 · 2023 · External reference

Association of pharmaceutical industry marketing of opioid products to physicians with subsequent opioid prescribing

10.1001/jamainternmed.2018.1999 · 2018 · External reference

Association of pharmaceutical industry marketing of opioid products with mortality from opioid-related overdoses

10.1001/jamanetworkopen.2018.6007 · 2019 · External reference

Associations between pharmaceutical industry payments to physicians and prescription of PARP inhibitors in the United States

10.1016/j.ygyno.2023.12.011 · 2024 · External reference

Disrupted federal funding for extramural cancer research

10.1001/jamaoncol.2025.4985 · 2026 · External reference

Unresolved reference

2012 · External reference

Trends in enforcement of National Comprehensive Cancer Network financial conflict of interest policy

10.1093/jncics/pkae120 · 2024 · External reference

The unintended consequences of conflict of interest disclosure

10.1001/jama.2012.154 · 2012 · External reference

Unresolved reference

2024 · External reference